Patient Guide: A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 171 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT06360094
Status: TERMINATED
Condition: Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Phase: PHASE2

Find a Study Location Near You

This study is available at 171 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Birmingham, Alabama
  • • Lakewood, Colorado
  • • Kissimmee, Florida
  • • And 168 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis - Join Clinical Trial NCTNCT06360094

How to Join This Clinical Trial - NCTNCT06360094

Learn how to participate in this PHASE2 trial studying an investigational therapy for Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis. Current status: TERMINATED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
TERMINATED
Study Identifier
NCTNCT06360094 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 171 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35294 - United States

Status: Contact for availability

Clinical Research Site

Lakewood, Colorado 80228 - United States

Status: Contact for availability

Clinical Research Site

Kissimmee, Florida 34746 - United States

Status: Contact for availability

Clinical Research Site

West Des Moines, Iowa 50266 - United States

Status: Contact for availability

Clinical Research Site

Warren, Michigan 48088 - United States

Status: Contact for availability

Clinical Research Site

Gulfport, Mississippi 39501 - United States

Status: Contact for availability

Clinical Research Site

Mount Kisco, New York 10549 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10032 - United States

Status: Contact for availability

Clinical Research Site

Durham, North Carolina 27710 - United States

Status: Contact for availability

And 161 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Idiopathic Pulmonary Fibrosis, Progressive Pulmonary Fibrosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation